PHAT icon

Phathom Pharmaceuticals
PHAT

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$21
49% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Glen Santangelo
9 Dec ‘25 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Matthew Caufield
75% 1-yr PHAT win rate
31 Oct ‘25 2 months ago